Atlas Trials

Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia

Clinical trial NCT02339740 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02339740
Sponsor
Children's Oncology Group
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
Start date
2015-07-21
Primary completion
2020-10-31
Enrollment
158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.